Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias

Fig. 1

Biomarker levels in the main diagnostic groups and CJD subtypes. CSF SNAP-25 (A) and Ng (C) levels in Creutzfeldt-Jakob disease (CJD) and non-prion rapidly progressive dementia (np-RPD). CSF SNAP-25 (B) and Ng (D) levels in sporadic CJD (sCJD) subtypes MM(V)1, VV2, MV2K, and MM(V)2C, and genetic CJD (gCJD) subtypes M2T and M1. Thick lines represent medians and interquartile ranges. CSF SNAP-25 and Ng values are expressed in a logarithmic scale. See the main text for all the P-values (Kruskal–Wallis followed by Dunn-Bonferroni post hoc test). Only subgroups comprising at least three cases are shown. Ng, neurogranin; SNAP-25, synaptosomal-associated protein 25

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193